Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy SPOC MIRACIP: … are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy Immunotherapy is an …
Published on: